Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-713.95%
operating margin TTM
-707.97%
revenue TTM
47.56 Million
revenue per share TTM
0.35$
valuation ratios | |
|---|---|
| pe ratio | -1.46 |
| peg ratio | -0.64 |
| price to book ratio | 0.66 |
| price to sales ratio | 10.50 |
| enterprise value multiple | -1.66 |
| price fair value | 0.66 |
profitability ratios | |
|---|---|
| gross profit margin | 86.84% |
| operating profit margin | -707.97% |
| pretax profit margin | -715.51% |
| net profit margin | -713.95% |
| return on assets | -37.31% |
| return on equity | -38.86% |
| return on capital employed | -40.46% |
liquidity ratio | |
|---|---|
| current ratio | 8.71 |
| quick ratio | 8.71 |
| cash ratio | 1.86 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 192.74 |
| cash conversion cycle | -192.74 |
| receivables turnover | 0.00 |
| payables turnover | 1.89 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.07 |
| debt equity ratio | 0.09 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.08 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -4.56 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.33 |
| cash per share | 6.64 |
| operating cash flow per share | -3.28 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -4.56 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -61.14 |
Frequently Asked Questions
When was the last time Vir Biotechnology, Inc. (NASDAQ:VIR) reported earnings?
Vir Biotechnology, Inc. (VIR) published its most recent earnings results on 04-11-2024.
What is Vir Biotechnology, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Vir Biotechnology, Inc. (NASDAQ:VIR)'s trailing twelve months ROE is -38.86%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Vir Biotechnology, Inc. (VIR) currently has a ROA of -37.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did VIR's net profit margin stand at?
VIR reported a profit margin of -713.95% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is VIR's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 8.71 in the most recent quarter. The quick ratio stood at 8.71, with a Debt/Eq ratio of 0.09.